On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJun 28, 2021 12:48 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Ready as Ottawa Review of Federal Cannabis Act Approaches

Canadian lawmakers are scheduled to assemble during Q4 to assess past, current, future state of legal cannabis market Pac Roots Cannabis has quietly positioned itself as an integrated producer of premium cannabis and hemp Pac Roots is generating revenue through a hemp JV, has access to exclusive cultivars, is completing a production facility, has an agreement for more land and recently bought an established cannabis lifestyle brand The Canadian government has taken a measured approach to legalization of marijuana, but now nearly three years in, advocates will be looking at meaningful progress with regards to regulations to support the industry…

Continue Reading

MondayJun 28, 2021 12:24 pm

11th Annual LD Micro Invitational Now on Demand Via SRAX Inc.’s (NASDAQ: SRAX) Sequire Platform

11th Annual LD Micro Invitational Conference now available on demand via SRAX’s Sequire investor analytics platform Conference featured 25-minute presentations by over 180 microcap companies, including Arch Therapeutics, and GreenPower Motor Company  Prominent keynote speakers included Jaime Rogozinski, Rishi Khanna and Matt Hulsizer  The 11th Annual LD Micro Invitational Conference is now available on demand via the Sequire SaaS investor analytics platform offered by SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies.  The Invitational features 25-minute presentations by over 180 companies on the verge of breaking out in their respective fields, including…

Continue Reading

MondayJun 28, 2021 11:42 am

Roth Capital Partners’ Virtual Healthcare Private Company Forum to Focus on Biotechnology, Pharmaceuticals and Medical Technologies

Roth’s Healthcare Private Company Forum is currently taking place  The investor-focused forum will feature a series of corporate fireside chats The conference will also play host to three investment panels Today, Roth Capital Partners (“Roth”) is hosting the Virtual Healthcare Private Company Forum. The event, which is now fully underway, features a number of different healthcare companies drawn from across the biotechnology, pharmaceuticals, and medical technologies verticals.   Roth has long been renowned for their experience and ever-growing network within the global healthcare industry, having been involved in more than 530 transactions for its healthcare clients since 2010, with a total…

Continue Reading

FridayJun 25, 2021 2:17 pm

RYAH Group Inc. (CSE: RYAH) Cannabis Clinical Trials Improve Due to Dose-Measuring Devices

Cannabis is a chemically variable plant making its clinical trials problematic, before the creation of dose-measuring devices RYAH Smart inhalers being used in one of the largest clinical studies of its kind focused on chronic pain  Restrictive funding and legislative barriers regarding cannabis are rapidly dissipating Regulating dose size in cannabis clinical trials has proven problematic from one test subject to another because cannabis is a chemically variable plant. RYAH Group (CSE: RYAH), a health care analytics and technology company, has created IoT dose-measuring devices backed by powerful data analytics, allowing for more control for variables within a clinical setting. …

Continue Reading

FridayJun 25, 2021 1:35 pm

Emaginos Inc. Offers Proprietary Solution to Broken Public School System

The public education system, where roughly 90% of students are enrolled, isn’t working.  No amount of resources can change the problems facing the public school system.  The Emaginos solution is focused on engaging students by providing a customized education for every child and hands-on learning opportunities.  Grades have been turned in, and the public school system has failed — at least in the area of science. According to the National Assessment of Educational Progress (“NAEP”) science assessment, only 36% of 4th graders were proficient in science in 2019, with 35% of 8th graders reaching proficiency and significantly fewer — 22% — 12th…

Continue Reading

FridayJun 25, 2021 1:16 pm

DSG Global Inc. (DSGT), Subsidiary IMC Unveil Array of New EVs at Experience Center Grand Opening Event

Quality, value, diversity hallmarks of EV grand opening event.  IMC has existing inventory already on hand, doesn’t require substantial amount of capital before seeing profitability. Company offers affordable vehicles with emphasis on great design, a green mindset, performance and functionality. DSG Global (OTCQB: DSGT), an emerging global technology company with an array of interconnecting businesses in some of the fastest-growing market sectors, and subsidiary Imperium Motor Company (“IMC”) unveiled more than two dozen electric-powered vehicles at the grand opening of the Imperium Motors Experience Center in Fairfield, California (https://nnw.fm/qDbE4). Held June 18–19, the grand opening event included interviews, press coverage,…

Continue Reading

FridayJun 25, 2021 12:52 pm

Sharing Services Global Corp. (SHRG) Unveils Plans for Subsidiary — The Happy Co. — to Expand into European Market

SHRG’s global expansion efforts will be the Happy Co.’s first introduction into the European market. Company planning to release entire U.S. product line on an NFR basis to customers in 21 European countries. Proprietary nootropic products are nutraceutical formulations derived from food sources that provide health benefits above and beyond basic nutritional value. Sharing Services Global (OTCQB: SHRG) has announced that its wholly owned subsidiary, the Happy Co., is preparing to launch into 21 European countries with its exclusive, high-quality products. The Happy Co. is a leading producer and distributor of nootropic, functional beverage products with a focus on health…

Continue Reading

FridayJun 25, 2021 12:11 pm

Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder and Chief Medical Officer Shares Company’s Groundbreaking Work in New Book

Dr. Dave Singh, Vivos Therapeutics Inc. founder and Chief Medical Officer, releases his new book titled Pneumopedics and Craniofacial Epigenetics The book is the product of Dr. Singh’s years of research and is a chronology of Vivo Therapeutics’ strides in innovation The book mainly covers craniofacial growth and developmental Genetics It also highlights the relationship between dentofacial anomalies and developmental deficiencies associated with downstream conditions such as Obstructive Sleep Apnea (“OSA”) Since its inception, Vivos Therapeutics (NASDAQ: VVOS) has been a trailblazer in diagnosing and treating mild-to-moderate Obstructive Sleep Apnea (“OSA”). Its main product — Vivos System — results from…

Continue Reading

FridayJun 25, 2021 11:51 am

Knightscope Autonomous Security Robot Gets Exposure Boost in Disney+ Episode of ‘Loki’ Series

Knightscope develops and manufactures autonomous security robots that utilize an array of technological tools to patrol and monitor client properties on a 24/7 basis   The company’s robots have provided more than a million hours of service to clients since 2015, and recently got high-profile attention through an appearance on the Disney+ streaming superhero series “Loki” Knightscope’s ASR robots are dedicated to helping make the United States safer as a whole, providing video and audio data reception, transmission and analysis, to determine if security concerns and the need for crime deterrence or other emergency intervention are present When Knightscope's K5 model…

Continue Reading

FridayJun 25, 2021 11:40 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Discusses Its Vision for Addressing Patient Needs

In 2021, Tryp Therapeutics plans on expanding its academic collaborations It also plans to initiate Phase 2a clinical studies for its synthetic psilocybin drug product as a way to determine efficacy in patient populations Tryp Therapeutics is constantly working on identifying alternative and better ways to control doses and control the patient experience in their dissociative state, mainly through innovations in drug formulation and delivery A primary objective of the administration of psilocybin is to increase the neuroplasticity of the brain Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently shed light on its operations and the vision that it has both…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217